CUSIP: 867781403
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Total 13F shares
-
1,468,220
-
Share change
-
+1,468,220
-
Total reported value
-
$3,546,194
-
Price per share
-
$2.45
-
Number of holders
-
12
-
Value change
-
+$3,546,194
-
Number of buys
-
12
Quarterly Holders Quick Answers
What is CUSIP 867781403?
CUSIP 867781403 identifies SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 867781403:
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2022
As of 31 Mar 2022,
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,468,220 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Empery Asset Management, LP, Hudson Bay Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), UBS Group AG, and NATIONAL BANK OF CANADA /FI/.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.